MORTALITY IN PEDIATRIC PHASE-I CLINICAL-TRIALS

被引：20
|
作者：
FURMAN, WL
PRATT, CB
RIVERA, GK
KRISCHER, JP
KAMEN, BA
VIETTI, TJ
机构：
[1] UNIV TENNESSEE, CTR HLTH SCI,COLL MED,DEPT PEDIAT, DIV HEMATOL ONCOL, MEMPHIS, TN 38163 USA
[2] UNIV TEXAS, SW MED CTR, DEPT PEDIAT, DALLAS, TX 75230 USA
[3] WASHINGTON UNIV, SCH MED, DEPT PEDIAT, ST LOUIS, MO 63110 USA
[4] ST LOUIS CHILDRENS HOSP, DIV HEMATOL ONCOL, ST LOUIS, MO 63178 USA
[5] GRP STAT OFF, GAINESVILLE, FL USA
[6] GRP OPERAT OFF, ST LOUIS, MO USA
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1989年 / 81卷 / 15期
关键词：
D O I：
10.1093/jnci/81.15.1193
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1193 / 1194
页数：2
相关论文
共 50 条
  • [31] BIOLOGIC EFFECTS AND SAFETY OF STAVUDINE - OVERVIEW OF PHASE-I AND PHASE-II CLINICAL-TRIALS
    SKOWRON, G
    JOURNAL OF INFECTIOUS DISEASES, 1995, 171 : S113 - S117
  • [32] CLINICAL ASPECTS OF PHASE-I TRIALS
    CALVERT, AH
    BRITISH JOURNAL OF CANCER, 1985, 52 (03) : 412 - 412
  • [33] DETERMINATION OF A POTENTIAL ANTIASTHMATIC COMPOUND, TIBENELAST, AND ITS APPLICATION TO PHASE-I CLINICAL-TRIALS
    PEYTON, AL
    ZIEGE, EA
    JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 529 (02): : 377 - 387
  • [34] PHARMACOLOGICALLY GUIDED PHASE-I CLINICAL-TRIALS BASED UPON PRECLINICAL DRUG DEVELOPMENT
    COLLINS, JM
    GRIESHABER, CK
    CHABNER, BA
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (16): : 1321 - 1326
  • [35] SENSATION SEEKING AMONGST HEALTHY-VOLUNTEERS PARTICIPATING IN PHASE-I CLINICAL-TRIALS
    FARRE, M
    LAMAS, X
    CAMI, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (04) : 405 - 409
  • [36] THE ROLE OF AN INITIAL SINGLE-BLIND PLACEBO PERIOD IN PHASE-I CLINICAL-TRIALS
    NONY, P
    BOISSEL, JP
    GIRARD, P
    LION, L
    HAUGH, MC
    FAREH, S
    DEBREYNE, B
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1994, 8 (02) : 185 - 187
  • [37] WHICH EXPERIMENTAL-DESIGN FOR PHASE-I CLINICAL-TRIALS - PROPOSAL FOR AN INVESTIGATIONAL APPROACH
    DURIEU, I
    GIRARD, P
    BOISSEL, JP
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1990, 4 : S77 - S80
  • [38] PHARMACOKINETICALLY GUIDED DOSE ESCALATION IN PHASE-I CLINICAL-TRIALS - COMMENTARY AND PROPOSED GUIDELINES
    NEWELL, DR
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (07): : 1083 - 1087
  • [39] A NOVEL STRATEGY FOR DOSE ESCALATION IN PHASE-I CLINICAL-TRIALS OF CHEMOTHERAPEUTIC-AGENTS
    SMITH, DB
    EWEN, C
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 214 - 214
  • [40] MUSCLE CRAMPING IN PHASE-I CLINICAL-TRIALS OF TIRAPAZAMINE (SR-4233) WITH AND WITHOUT RADIATION
    DOHERTY, N
    HANCOCK, SL
    KAYE, S
    COLEMAN, CN
    SHULMAN, L
    MARQUEZ, C
    MARISCAL, C
    RAMPLING, R
    SENAN, S
    ROEMELING, RV
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 29 (02): : 379 - 382
12345